Now showing items 1-2 of 2

    • 3-Methoxy-Phencyclidine Induced Psychotic Disorder: A Literature Review and an 18 F-FDG PET/CT Case Report 

      Pepe, Maria; Di Nicola, Marco; Cocciolillo, Fabrizio; Chiappini, Stefania; Martinotti, Giovanni; Calcagni, Maria Lucia; Sani, Gabriele (2024-03-31)
      New Psychoactive Substances (NPS) are modifying the drug scenario worldwide and have become a public health concern because of their toxicological profiles and their harmful physical/psychological effects. 3-Methoxy-Phencyclidine ...
    • Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment‐resistant depression 

      the REAL‐ESK Study Group; Martinotti, Giovanni; Dell'Osso, Bernardo; Di Lorenzo, Giorgio; Maina, Giuseppe; Bertolino, Alessandro; Clerici, Massimo; Barlati, Stefano; Rosso, Gianluca; Di Nicola, Marco; Marcatili, Matteo; d'Andrea, Giacomo; Cavallotto, Clara; Chiappini, Stefania; De Filippis, Sergio; Nicolò, Giuseppe; De Fazio, Pasquale; Andriola, Ileana; Zanardi, Raffaella; Nucifora, Domenica; Di Mauro, Stefania; Bassetti, Roberta; Pettorruso, Mauro; McIntyre, Roger S.; Sensi, Stefano L.; di Giannantonio, Massimo; Vita, Antonio; Baldacci, Giulia; Belletti, Sandro; Bellomo, Antonello; Benatti, Beatrice; Carminati, Matteo; Carullo, Rosalba; de Berardis, Domenico; de Filippis, Renato; Chiaie, Roberto Delle; di Carlo, Francesco; Di Petta, Gilberto; Galluzzo, Alessandro; Giorgelli, Valentina; Lombardozzi, Ginevra; Martiadis, Vassilis; Mattei, Chiara; Mosca, Alessio; Niolu, Cinzia; Olivola, Miriam; Percudani, Mauro; Pepe, Maria; Rossi, Eros; Scardigli, Maria Ilaria; Tatì, Filippo (2023-01-18)
      Background: Bipolar depression accounts for most of the disease duration in type I and type II bipolar disorder (BD), with few treatment options, often poorly tolerated. Many individuals do not respond to first‐line ...